A Phase 2 Study Of Titrating-Dose Lonafarnib Plus Ritonavir In Patients With Chronic Hepatitis D: Interim Results From The Lonafarnib With Ritonavir In HDV-4 (LOWR HDV-4) Study

Wedemeyer Heiner; Port Kerstin; Deterding Katja; Wranke Anika; Kirschner Janina; Martins Eduardo B.; Glenn Jeffrey; Cornberg Markus; Manns Michael P.

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >A Phase 2 Study Of Titrating-Dose Lonafarnib Plus Ritonavir In Patients With Chronic Hepatitis D: Interim Results From The Lonafarnib With Ritonavir In HDV-4 (LOWR HDV-4) Study

【24h】

A Phase 2 Study Of Titrating-Dose Lonafarnib Plus Ritonavir In Patients With Chronic Hepatitis D: Interim Results From The Lonafarnib With Ritonavir In HDV-4 (LOWR HDV-4) Study

机译：慢性丙型肝炎患者滴定剂LONAFARNIB PLUSRITONAVIR的第2阶段研究：LONAFARNIB与HDV-4（LOWR HDV-4）研究中的临时结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共2页
作者
Wedemeyer Heiner; Port Kerstin; Deterding Katja; Wranke Anika; Kirschner Janina; Martins Eduardo B.; Glenn Jeffrey; Cornberg Markus; Manns Michael P.;
展开▼
作者单位

Hannover Med Sch Dept Gastroenterol Hepatol &

Endocrinol Hannover Germany;

Hannover Med Sch Dept Gastroenterol Hepatol &

Endocrinol Hannover Germany;

Hannover Med Sch Dept Gastroenterol Hepatol &

Endocrinol Hannover Germany;

Hannover Med Sch Dept Gastroenterol Hepatol &

Endocrinol Hannover Germany;

Hannover Med Sch Dept Gastroenterol Hepatol &

Endocrinol Hannover Germany;

Eiger Biopharmaceut Palo Alto CA USA;

Stanford Univ Sch Med Div Gastroenterol &

Hepatol Palo Alto CA 94304 USA;

Hannover Med Sch Dept Gastroenterol Hepatol &

Endocrinol Hannover Germany;

Hannover Med Sch Dept Gastroenterol Hepatol &

Endocrinol Hannover Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. A Phase 2 Study Of Titrating-Dose Lonafarnib Plus Ritonavir In Patients With Chronic Hepatitis D: Interim Results From The Lonafarnib With Ritonavir In HDV-4 (LOWR HDV-4) Study [J] . Wedemeyer Heiner, Port Kerstin, Deterding Katja, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：慢性丙型肝炎患者滴定剂LONAFARNIB PLUSRITONAVIR的第2阶段研究：LONAFARNIB与HDV-4（LOWR HDV-4）研究中的临时结果
2. O‐010: A phase 2 dose‐optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—analysis from the LOWR HDV‐2 study using the robogene ? ? real‐time qPCR HDV RNA assay [J] . Journal of viral hepatitis. . 2018,第S1期

机译：O-010：LONAFARNIB与Ritonavir的一个相2剂量优化研究，用于使用ROBOGENE治疗LOWR HDV-2研究的慢性δ肝炎分析？还实时QPCR HDV RNA测定
3. Modeling hepatitis delta virus dynamics during ritonavir boosted lonafarnib treatment-the LOWR HDV-3 study [J] . Dubey Preeti, Koh Christopher, Surana Pallavi, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：升高肝炎Delta病毒动力学在Ritonavir Boosted Lonafarnib治疗期间 - LOWR HDV-3研究
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The Development and Psychometric Testing of an Inventory to Measure Health-Focused Perceived Family Support and Communication Behaviors with Chronic Disease Patients: A Three-Phase Study [D] . Harsin, Amanda M. 2019

机译：对库存的发展和心理测量测试，以测量慢性疾病患者的健康焦点的家庭支持和沟通行为：三相研究
6. Population Pharmacokinetics of Paritaprevir Ombitasvir Dasabuvir Ritonavir and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies [O] . Sven Mensing, Akshanth R. Polepally, Denise König, 2016

机译：丙型肝炎病毒基因型1感染患者中ParitaprevirOmbitasvirDasabuvirRitonavir和Ribavirin的群体药代动力学：9个1b / 2期研究的组合分析
7. Phase 1 study of lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib [O] . Jorge Cortes, Elias Jabbour, George Q. Daley, 2007

机译：LONAFARNIB（SCH 66336）和IMATINIB甲磺酸伊斯洛替尼血症患者的第1阶段研究，慢性骨髓性白血病患者失败的伊马替尼患者失败了

A Phase 2 Study Of Titrating-Dose Lonafarnib Plus Ritonavir In Patients With Chronic Hepatitis D: Interim Results From The Lonafarnib With Ritonavir In HDV-4 (LOWR HDV-4) Study

著录项

引文网络

相似文献

相关主题

期刊订阅